SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-046814
Filing Date
2024-05-28
Accepted
2024-05-28 09:00:12
Documents
4
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0205641-01.htm DEF 14A 795852
2 GRAPHIC tpasithea_logo.jpg GRAPHIC 96226
3 GRAPHIC tproxy_001.jpg GRAPHIC 924735
4 GRAPHIC tproxy_002.jpg GRAPHIC 851699
  Complete submission text file 0001213900-24-046814.txt   3376899
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40804 | Film No.: 24986473
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)